-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Biogen to Outperform, Announces $300 Price Target

Benzinga·08/13/2026 17:18:06
Listen to the news
Wolfe Research analyst Alexandria Hammond upgrades Biogen (NASDAQ:BIIB) from Peer Perform to Outperform and announces $300 price target.